Viewing Study NCT00758693


Ignite Creation Date: 2025-12-25 @ 1:19 AM
Ignite Modification Date: 2025-12-25 @ 11:28 PM
Study NCT ID: NCT00758693
Status: WITHDRAWN
Last Update Posted: 2012-01-11
First Post: 2008-09-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Frontline Treatment With Bendamustine in Combination With Rituximab in Adults Age 65 or Older With Chronic Lymphocytic Leukemia (CLL)
Sponsor: University of Kentucky
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module